X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-mandates-label-updates-car-t-cancer-therapies-2024-04-18/
https://www.prnewswire.com/news-releases/novartis-kesimpta-six-year-efficacy-data-show-substantial-benefits-in-recently-diagnosed-treatment-naive-people-with-relapsing-multiple-sclerosis-302118899.html
https://www.globenewswire.com/news-release/2024/04/15/2863093/0/en/New-Novartis-Fabhalta-iptacopan-data-show-clinically-meaningful-and-statistically-significant-proteinuria-reduction-of-38-3-versus-placebo-for-patients-with-IgA-nephropathy-IgAN.html
https://www.fiercepharma.com/pharma/novartis-touts-surrogate-endpoint-win-nabs-priority-review-fabhalta-igan
https://www.fiercebiotech.com/biotech/novartis-pays-150m-arvinas-phase-3-ready-prostate-cancer-protein-degrader
https://www.novartis.com/news/novartis-implements-manufacturing-adjustments-ribociclib-ensure-alignment-latest-regulatory-standards-ebc-end-q2
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-begins-tender-offer-morphosys-2024-04-11/
https://www.globenewswire.com/news-release/2024/04/11/2861280/0/en/Novartis-tender-offer-for-MorphoSys-AG-commences.html
https://www.reuters.com/business/world-at-work/novartis-cut-680-jobs-product-development-2024-04-09/
Market Place
Share 
